EW vs. BAX

In the year-to-date period, EW achieves a -0.47% return, which is significantly lower than BAX's 6.48% return. Over the past 10 years, EW has outperformed BAX with an annualized return of 13.01%, while BAX has yielded a comparatively lower -0.34% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Baxter International Inc. (BAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EW Sharpe Ratio is -0.38, which is comparable to the BAX Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of EW and BAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

EW has not paid dividends to shareholders, while BAX's dividend yield for the trailing twelve months is around 2.98%.

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum BAX drawdown of -68.86%. Use the drawdown chart below to compare losses from any high point for EW and BAX. For additional features, visit the drawdowns tool.

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Baxter International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.